Cynosure, Inc.

Cynosure, Inc.

CYNO
Cynosure, Inc.US flagNASDAQ
66.00
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Healthcare
Industry
Medical - Equipment & Services
Address
IPO Date
Jan 4, 2016
Business
Cynosure, Inc. (CYNO) develops and manufactures energy-based laser and radiofrequency (RF) systems for aesthetic and medical treatments, including hair removal, skin revitalization, pigmentary concerns, tattoo removal, vascular treatments, wrinkle reduction, body contouring, scar reduction, gynecological health applications, and fine line treatments; key products comprise the PicoSure Pro picosecond laser platform, Elite iQ dual-wavelength system, Genius RF microneedling device, Potenza RF microneedling system, and XERF multi-frequency monopolar RF treatment. Founded in 1991 and headquartered in Westford, Massachusetts, the company operates globally through subsidiaries and regional affiliates serving practitioners, physicians, and aesthetic businesses in North America, Europe, Asia-Pacific, Middle East, and other markets. In 2024, Cynosure merged with Lutronic, creating Cynosure Lutronic as a leading provider leveraging combined innovation in aesthetic laser and RF technologies to expand market reach and product portfolios.